Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

• Conditions: Cancer

• Registration Number: NCT01148407
• Lead Sponsor: University of Vermont

Brief Summary

Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-06
• Study First Submitted: 2010-06-21
• Study First Submitted QC: 2010-06-21
• Study First Posted: 2010-06-22
• Status Verified: 2011-04
• Last Update Submitted: 2011-04-21
• Last Update Posted: 2011-04-22
• Primary Completion: 2012-08
• Study Completion: 2013-08

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients with a diagnosis of malignancy

Exclusion Criteria

• Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

University of Vermont/Fletcher Allen Health Care; 🇺🇸 Burlington, Vermont, United States